N-acetylaspartate (NAA) and N-acetylaspartylglutamate (NAAG) promote growth and inhibit differentiation of glioma stem-like cells

Journal of Biological Chemistry

Volumn 288, Issue 36, 2013, Pages 26188-26200

  Long, Patrick M ^a   Moffett, John R ^b   Namboodiri, Aryan M A ^b   Viapiano, Mariano S ^c   Lawler, Sean E ^c   Jaworski, Diane M ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

N-ACETYLASPARTATE; PRIMARY SOURCES;

BIOCHEMISTRY; TUMORS;

VOLATILE FATTY ACIDS;

ACETIC ACID; ASPARTOACYLASE; CARRIER PROTEIN; N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID; NADC3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTROCYTE; BIOAVAILABILITY; BRAIN METABOLISM; CANCER STEM CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL NUCLEUS; CONTROLLED STUDY; CYTOSOL; ENZYME REGULATION; GLIOBLASTOMA; GLIOMA; GLIOMA STEM LIKE CELL; MOUSE; NONHUMAN; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN FUNCTION;

CANCER STEM CELLS; DIFFERENTIATION; METABOLISM; OLIGODENDROCYTES; PROLIFERATION;

AMIDOHYDROLASES; ANIMALS; ASPARTIC ACID; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL PROLIFERATION; DIPEPTIDES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; NEUROPROTECTIVE AGENTS; OLIGODENDROGLIOMA;

EID: 84883676327     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.487553     Document Type: Article

References (49)

1. Liu, C., Sage, J. C., Miller, M. R., Verhaak, R. G., Hippenmeyer, S., Vogel, H., Foreman, O., Bronson, R. T., Nishiyama, A., Luo, L., and Zong, H. (2011) Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell 146, 209-221
2. Mehta, V., and Namboodiri, M. A. (1995) N-Acetylaspartate as an acetyl source in the nervous system. Brain Res. Mol. Brain Res. 31, 151-157
3. Goldstein, F. B. (1959) Biosynthesis of N-acetyl-L-aspartic acid. Biochim. Biophys. Acta 33, 583-584
4. Lu, Z. H., Chakraborty, G., Ledeen, R. W., Yahya, D., and Wu, G. (2004) N-Acetylaspartate synthase is bimodally expressed in microsomes and mitochondria of brain. Molec. Brain Res. 122, 71-78
5. Moffett, J. R., Ross, B., Arun, P., Madhavarao, C. N., and Namboodiri, A. M. (2007) N-Acetylaspartate in the CNS. From neurodiagnostics to neurobiology. Prog. Neurobiol. 81, 89-131
6. Becker, I., Lodder, J., Gieselmann, V., and Eckhardt, M. (2010) Molecular characterization of N-acetylaspartylglutamate synthetase. J. Biol. Chem. 285, 29156-29164
7. Collard, F., Stroobant, V., Lamosa, P., Kapanda, C. N., Lambert, D. M., Muccioli, G. G., Poupaert, J. H., Opperdoes, F., and Van Schaftingen, E. (2010) Molecular identification of N-acetylaspartylglutamate synthase and -citrylglutamate synthase. J. Biol. Chem. 285, 29826-29833
8. Neale, J. H., Olszewski, R. T., Zuo, D., Janczura, K. J., Profaci, C. P., Lavin, K. M., Madore, J. C., and Bzdega, T. (2011) Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family. J. Neurochem. 118, 490-498
9. D'Adamo, A. F., Jr., Smith, J. C., and Woiler, C. (1973) The occurrence of N-acetylaspartate amidohydrolase (aminoacylase II) in the developing rat. J. Neurochem. 20, 1275-1278
10. Goldberg, R. P., and Brunengraber, H. (1980) Contributions of cytosolic and mitochondrial acetyl-CoA syntheses to the activation of lipogenic acetate in rat liver. Adv. Exp. Med. Biol. 132, 413-418
11. Fujino, T., Kondo, J., Ishikawa, M., Morikawa, K., and Yamamoto, T. T. (2001) Acetyl-CoA synthetase 2, a mitochondrial matrix enzyme involved in the oxidation of acetate. J. Biol. Chem. 276, 11420-11426
12. Madhavarao, C. N., Arun, P., Moffett, J. R., Szucs, S., Surendran, S., Matalon, R., Garbern, J., Hristova, D., Johnson, A., Jiang, W., and Namboodiri, M. A. (2005) DefectiveN-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease. Proc. Natl. Acad. Sci. U.S.A. 102, 5221-5226
13. Hershfield, J. R., Madhavarao, C. N., Moffett, J. R., Benjamins, J. A., Garbern, J. Y., and Namboodiri, A. (2006) Aspartoacylase is a regulated nuclear- cytoplasmic enzyme. FASEB J. 20, 2139-2141
14. Moffett, J. R., Arun, P., Ariyannur, P. S., Garbern, J. Y., Jacobowitz, D. M., and Namboodiri, A. M. (2011) Extensive aspartoacylase expression in the rat central nervous system. Glia 59, 1414-1434
15. Ariyannur, P. S., Moffett, J. R., Madhavarao, C. N., Arun, P., Vishnu, N., Jacobowitz, D. M., Hallows, W. C., Denu, J. M., and Namboodiri, A. M. (2010) Nuclear-cytoplasmic localization of acetyl coenzyme a synthetase- 1 in the rat brain. J. Comp. Neurol. 518, 2952-2977
16. Kaul, R., Gao, G. P., Balamurugan, K., and Matalon, R. (1993) Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease. Nat. Genet. 5, 118-123
17. Kumar, S., Biancotti, J. C., Matalon, R., and de Vellis, J. (2009) Lack of aspartoacylase activity disrupts survival and differentiation of neural progenitors and oligodendrocytes in a mouse model of Canavan disease. J. Neurosci. Res. 87, 3415-3427
18. Mattan, N. S., Ghiani, C. A., Lloyd, M., Matalon, R., Bok, D., Casaccia, P., and de Vellis, J. (2010) Aspartoacylase deficiency affects early postnatal development of oligodendrocytes and myelination. Neurobiol. Dis. 40, 432-443
19. Rijpkema, M., Schuuring, J., van der Meulen, Y., van der Graaf, M., Bernsen, H., Boerman, R., van der Kogel, A., and Heerschap, A. (2003) Characterization of oligodendrogliomas using short echo time 1HMRspectroscopic imaging. NMR Biomed. 16, 12-18
20. Reitman, Z. J., Jin, G., Karoly, E. D., Spasojevic, I., Yang, J., Kinzler, K. W., He, Y., Bigner, D. D., Vogelstein, B., and Yan, H. (2011) Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome. Proc. Natl. Acad. Sci. U.S.A. 108, 3270-3275
21. Jung, M., Krämer, E., Grzenkowski, M., Tang, K., Blakemore, W., Aguzzi, A., Khazaie, K., Chlichlia, K., von Blankenfeld, G., and Kettenmann, H. (1995) Lines of murine oligodendroglial precursor cells immortalized by an activated neu tyrosine kinase show distinct degrees of interaction with axons in vitro and in vivo. Eur. J. Neurosci. 7, 1245-1265
22. Trotter, J., Bitter-Suermann, D., and Schachner, M. (1989) Differentiation- regulated loss of the polysialylated embryonic form and expression of the different polypeptides of the neural cell adhesion molecule by cultured oligodendrocytes and myelin. J. Neurosci. Res. 22, 369-383
23. Bello-Morales, R., de Marco, M. C., Aranda, J. F., Matesanz, F., Alcina, A., and López-Guerrero, J. A. (2009) Characterization of the MAL2-positive compartment in oligodendrocytes. Exp. Cell Res. 315, 3453-3465
24. Joubert, L., Foucault, I., Sagot, Y., Bernasconi, L., Duval, F., Alliod, C., Frossard, M. J., Pescini Gobert, R., Curchod, M. L., Salvat, C., Nichols, A., Pouly, S., Rommel, C., Roach, A., and Hooft van Huijsduijnen, R. (2010) Chemical inducers and transcriptional markers of oligodendrocyte differentiation. J. Neurosci. Res. 88, 2546-2557
25. Madhavarao, C. N., Moffett, J. R., Moore, R. A., Viola, R. E., Namboodiri, M. A., and Jacobowitz, D. M. (2004) Immunohistochemical localization of aspartoacylase in the rat central nervous system. J. Comp. Neurol. 472, 318-329
26. Lluri, G., Langlois, G. D., Soloway, P. D., and Jaworski, D. M. (2008) Tissue inhibitor of metalloproteinase-2 (TIMP-2) regulates myogenesis and 1 integrin expression in vitro. Exp. Cell Res. 314, 11-24
27. Jaworski, D. M., and Pérez-Martínez, L. (2006) Tissue inhibitor of metalloproteinase- 2 (TIMP-2) expression is regulated by multiple neural differentiation signals. J. Neurochem. 98, 234-247
28. Kirmani, B. F., Jacobowitz, D. M., and Namboodiri, M. A. (2003) Developmental increase of aspartoacylase in oligodendrocytes parallels CNS myelination. Brain Res. Dev. Brain Res. 140, 105-115
29. Brazel, C. Y., Nuñez, J. L., Yang, Z., and Levison, S. W. (2005) Glutamate enhances survival and proliferation of neural progenitors derived from the subventricular zone. Neuroscience 131, 55-65
30. Di Giorgi-Gerevini, V., Melchiorri, D., Battaglia, G., Ricci-Vitiani, L., Ciceroni, C., Busceti, C. L., Biagioni, F., Iacovelli, L., Canudas, A. M., Parati, E., De Maria, R., and Nicoletti, F. (2005) Endogenous activation of metabotropic glutamate receptors supports the proliferation and survival of neural progenitor cells. Cell Death Differ. 12, 1124-1133
31. Luyt, K., Váradi, A., Durant, C. F., and Molnár, E. (2006) Oligodendroglial metabotropic glutamate receptors are developmentally regulated and involved in the prevention of apoptosis. J. Neurochem. 99, 641-656
32. Berger, U. V., Luthi-Carter, R., Passani, L. A., Elkabes, S., Black, I., Konradi, C., and Coyle, J. T. (1999) Glutamate carboxypeptidase II is expressed by astrocytes in the adult rat nervous system. J. Comp. Neurol. 415, 52-64
33. Le Coq, J., An, H. J., Lebrilla, C., and Viola, R. E. (2006) Characterization of human aspartoacylase. The brain enzyme responsible for Canavan disease. Biochemistry 45, 5878-5884
34. Persson, A. I., Petritsch, C., Swartling, F. J., Itsara, M., Sim, F. J., Auvergne, R., Goldenberg, D. D., Vandenberg, S. R., Nguyen, K. N., Yakovenko, S., Ayers-Ringler, J., Nishiyama, A., Stallcup, W. B., Berger, M. S., Bergers, G., McKnight, T. R., Goldman, S. A., and Weiss, W. A. (2010) Non-stem cell origin for oligodendroglioma. Cancer Cell 18, 669-682
35. Kaul, R., Casanova, J., Johnson, A. B., Tang, P., and Matalon, R. (1991) Purification, characterization, and localization of aspartoacylase from bovine brain. J. Neurochem. 56, 129-135
36. Kaul, R., Gao, G. P., Matalon, R., Aloya, M., Su, Q., Jin, M., Johnson, A. B., Schutgens, R. B., and Clarke, J. T. (1996) Identification and expression of eight novel mutations among non-Jewish patients with Canavan disease. Am. J. Hum. Genet. 59, 95-102
37. Verhaak, R. G., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., Alexe, G., Lawrence, M., O'Kelly, M., Tamayo, P., Weir, B. A., Gabriel, S., Winckler, W., Gupta, S., Jakkula, L., Feiler, H. S., Hodgson, J. G., James, C. D., Sarkaria, J. N., Brennan, C., Kahn, A., Spellman, P. T., Wilson, R. K., Speed, T. P., Gray, J. W., Meyerson, M., Getz, G., Perou, C. M., Hayes, D. N., and Cancer Genome Atlas Research, N. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17, 98-110
38. Chinnaiyan, P., Kensicki, E., Bloom, G., Prabhu, A., Sarcar, B., Kahali, S., Eschrich, S., Qu, X., Forsyth, P., and Gillies, R. (2012) The metabolomic signature of malignant glioma reflects accelerated anabolic metabolism. Cancer Res. 72, 5878-5888
39. Phillips, H. S., Kharbanda, S., Chen, R., Forrest, W. F., Soriano, R. H., Wu, T. D., Misra, A., Nigro, J. M., Colman, H., Soroceanu, L., Williams, P. M., Modrusan, Z., Feuerstein, B. G., and Aldape, K. (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9, 157-173
40. Sanson, M., Marie, Y., Paris, S., Idbaih, A., Laffaire, J., Ducray, F., El Hallani, S., Boisselier, B., Mokhtari, K., Hoang-Xuan, K., and Delattre, J. Y. (2009) Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J. Clin. Oncol. 27, 4150-4154
41. Labussière, M., Idbaih, A., Wang, X. W., Marie, Y., Boisselier, B., Falet, C., Paris, S., Laffaire, J., Carpentier, C., Crinière, E., Ducray, F., El Hallani, S., Mokhtari, K., Hoang-Xuan, K., Delattre, J. Y., and Sanson, M. (2010) All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2. Neurology 74, 1886-1890
42. Piaskowski, S., Bienkowski, M., Stoczynska-Fidelus, E., Stawski, R., Sieruta, M., Szybka, M., Papierz, W., Wolanczyk, M., Jaskolski, D. J., Liberski, P. P., and Rieske, P. (2011) Glioma cells showing IDH1 mutation cannot be propagated in standard cell culture conditions. Br. J. Cancer 104, 968-970
43. Turcan, S., Rohle, D., Goenka, A., Walsh, L. A., Fang, F., Yilmaz, E., Campos, C., Fabius, A. W., Lu, C., Ward, P. S., Thompson, C. B., Kaufman, A., Guryanova, O., Levine, R., Heguy, A., Viale, A., Morris, L. G., Huse, J. T., Mellinghoff, I. K., and Chan, T. A. (2012) IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483, 479-483
44. Menendez, J. A., and Lupu, R. (2007) Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer 7, 763-777
45. Bjartmar, C., Battistuta, J., Terada, N., Dupree, E., and Trapp, B. D. (2002) N-Acetylaspartate is an axon-specific marker of mature white matter in vivo. A biochemical and immunohistochemical study on the rat optic nerve. Ann. Neurol. 51, 51-58
46. Lyssiotis, C. A., Walker, J., Wu, C., Kondo, T., Schultz, P. G., and Wu, X. (2007) Inhibition of histone deacetylase activity induces developmental plasticity in oligodendrocyte precursor cells. Proc. Natl. Acad. Sci. U.S.A. 104, 14982-14987
47. Wellen, K. E., Hatzivassiliou, G., Sachdeva, U. M., Bui, T. V., Cross, J. R., and Thompson, C. B. (2009) ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324, 1076-1080
48. Madiraju, P., Pande, S. V., Prentki, M., and Madiraju, S. R. (2009) Mitochondrial acetylcarnitine provides acetyl groups for nuclear histone acetylation. Epigenetics 4, 399-403
49. Bitto, E., Bingman, C. A., Wesenberg, G. E., McCoy, J. G., and Phillips, G. N., Jr. (2007) Structure of aspartoacylase, the brain enzyme impaired in Canavan disease. Proc. Natl. Acad. Sci. U.S.A. 104, 456-461